L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found

Read more

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Read more

T Cells Confer Protection to Three Main SARS-CoV-2 Variants

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Of the 45 noteworthy genetic mutations

Read more

First COVID-19 Case May Have Emerged Earlier Than Thought

In an article published in  Science, researchers examine aspects of the evolutionary dynamics and index cases of the SARS-CoV-2 pandemic,

Read more

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

In a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can

Read more

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Lipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and

Read more

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from

Read more

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),

Read more